Consider the current dip in Bitcoin (BTC) as a buying opportunity, as the market is overly focused on short-term fears while ignoring bullish long-term catalysts. For a "blue chip" way to gain Bitcoin exposure, look at MicroStrategy (MSTR), which has shown relative strength during recent downturns. A compelling way to invest in the Solana (SOL) ecosystem is through DFDV, which offers a 10% yield and a valuable warrant with a $22.50 strike price expiring in 2028. The recent irrational sell-off in Hims & Hers Health (HIMS) presents an attractive entry point around $51-$53 ahead of major growth catalysts like new product lines and international expansion. Lastly, view the recent drop in Tesla (TSLA) as a chance to buy, as the market is discounting strong fundamentals like the European Model Y launch and progress on its Robotaxi network.

Bitcoin (BTC)

• The price recently dropped from a high of $115,000 down to $110,000 due to market fears over trade tensions between the US and China.
• Despite the price drop, the speaker pointed out two very bullish news items:
  • The US Department of Justice is looking to seize $15 billion worth of Bitcoin from a scam. The speaker believes this BTC would be added to a US "strategic Bitcoin reserve," which would be a major positive.
  • Elon Musk has once again spoken positively about Bitcoin, highlighting that it is based on energy, which cannot be faked or printed like traditional (fiat) currency. The speaker notes that in the last cycle, Musk's support triggered a rally.
• The current market is ignoring this positive news and is instead focused on macro-economic fears related to tariffs.

Takeaways

• The speaker sees the current price dip as a buying opportunity, driven by short-term market fear rather than a change in Bitcoin's fundamental value.
• The potential for the US government to hold a strategic Bitcoin reserve and renewed positive sentiment from influential figures like Elon Musk are seen as significant long-term bullish catalysts.
• Investors may see the current weakness as a chance to accumulate Bitcoin before the market potentially shifts its focus back to these positive developments.

MicroStrategy (MSTR)

• The speaker refers to the company as "strategy" and "MSDR".
• On a day when Bitcoin was down 2.5%, MSTR was only down 1.93%.
• This outperformance supports the speaker's thesis of sticking with "blue chip" Bitcoin-related stocks as a "flight to safety" within the crypto equity space.
• The speaker has strong conviction in MSTR, calling it the "leader" and the "winner" among Bitcoin proxy stocks and noting they have been a long-term holder.

Takeaways

• MSTR is presented as a more stable, "blue chip" way to gain Bitcoin exposure compared to smaller, more volatile proxy stocks.
• Its relative strength during a market downturn could make it an attractive option for investors who want exposure to Bitcoin but with potentially less volatility than holding the asset directly or investing in smaller crypto-related companies.
• The speaker's personal high conviction suggests it is a core holding for those bullish on Bitcoin.

Nakamoto (NAKA)

• The speaker refers to the company as "KindlyMD" and "NACA".
• The stock is considered increasingly interesting and compelling because it is trading at a discount, with a fully diluted Market to Net Asset Value (MNAV) of 0.92.
• It is presented as a "cheap" way to get Bitcoin exposure, especially compared to other proxies that may have liabilities (the speaker mentions a competitor with a DOJ issue).
• The stock has experienced a massive drop of almost 97% from its peak, suggesting the "dust has settled" after initial hype.
• The speaker believes NAKA has "hype potential" in a future bull market.

Takeaways

• For investors looking for a higher-risk, higher-reward play on Bitcoin, NAKA could be an interesting opportunity due to its significant discount to its asset value and its massive drawdown from previous highs.
• While the speaker is not personally buying it yet (preferring MSTR), they state that if they were adding to their Bitcoin position, they would consider using a cheap proxy like NAKA. This implies it's a speculative buy for those willing to take on more risk.

MetaPlanet (MTPLF)

• The stock experienced an "insane" sell-off, dropping 10% in a single day.
• The speaker mentions holding a "little gamble" on the stock, indicating it is a small, speculative position in their portfolio.
• Its poor performance is used as an example to reinforce the strategy of sticking with the "winner" in the space, which the speaker identifies as MSTR.

Takeaways

• MTPLF is positioned as a much riskier, more volatile Bitcoin proxy compared to MSTR.
• The significant sell-off highlights the risks associated with smaller, less-established crypto-related stocks. Investors should be aware of this high volatility.

Solana (SOL)

• The speaker is bullish on the "world computer" thesis, believing that Web3 platforms like Solana will disrupt and "delete entire industries" including banking, insurance, gaming, and more.
• They view the main competition in this space as being between Ethereum (ETH) and Solana (SOL).
• The speaker personally prefers SOL over ETH due to its superior data and throughput (transaction speed), though they acknowledge that "Wall Street likes ETH a little better."

Takeaways

• Investing in SOL is framed as a long-term bet on the future of Web3 infrastructure.
• For investors who believe in the transformative potential of blockchain beyond just Bitcoin, SOL is presented as a top contender with strong technological advantages.
• The note about Wall Street's preference for ETH suggests that while SOL may be technologically superior in the speaker's view, ETH might have stronger institutional backing for now.

DFDV (Deep Value Data)

• The speaker owns and likes this stock as a way to get exposure to Solana (SOL).
• A major bullish catalyst is a recent warrant offering: investors receive one warrant (with a $22.50 strike price, expiring in 2028) for every 10 shares of DFDV they own. The speaker sees this as a "beautiful gift" designed to hurt short-sellers.
• The company was founded by former executives from the crypto exchange Kraken.
• The founders are extremely bullish on Solana, with a long-term (10-20 year) price target of a 50x increase for SOL.
• DFDV generates a 10% yield on its Solana holdings through staking and DeFi strategies, and the stock itself is trading at a discount to its Net Asset Value (MNAV).
• The company is expanding internationally, with new divisions in the UK, Korea, and Japan.

Takeaways

• DFDV is presented as a compelling and "cheap" way to invest in Solana, offering a combination of discounted asset value, a high yield, and a bonus from the warrant offering.
• It's a good option for investors who are bullish on SOL and want to benefit from a management team with deep crypto industry experience.
• The 10% yield provides a way to generate income while holding a volatile crypto-related asset.

Hims & Hers Health (HIMS)

• The stock sold off by 6% despite having no connection to the tariff news driving the market down. The speaker believes this was an irrational move.
• The stock has been in a "valley of despair" for about four months, which could present a buying opportunity.
• The speaker highlighted several upcoming bullish catalysts:
  • New product lines for testosterone and menopause.
  • Strong continued growth in GLP-1 weight-loss drugs.
  • Expansion into Europe (via the Ziva acquisition) and Canada (launching semaglutide).
• The speaker believes the stock is "too cheap" at current levels, mentioning prices of $53 and $51 as attractive entry points.

Takeaways

• HIMS is presented as a growth stock that has been unfairly punished by market sentiment and is disconnected from its strong fundamental catalysts.
• Investors looking for opportunities in the telehealth and pharmaceutical space may find HIMS attractive due to its multiple growth avenues (weight loss, international expansion) and its recent price decline.
• The stock is considered very cheap by the speaker, suggesting significant upside potential if and when the market recognizes its growth story.

Tesla (TSLA)

• The speaker believes the stock's recent drop of over 3% is illogical, as TSLA is "pretty darn immune" from the US-China tariff issues that are worrying the market.
• A sharp contrast is drawn with General Motors (GM), which wrote off $1.6 billion in failed EV investments, yet saw its stock price rise 2.5%. This is used to show how irrational the market is.
• Several key bullish points were emphasized:
  • The Robotaxi network is expanding into a new market (Colorado).
  • The Optimus robot project is reportedly progressing faster than expected.
  • The Model Y Standard Range is expected to "sell like hotcakes" in Europe, priced at €37,000 in Germany, which is significantly cheaper than competing EVs from Skoda or Renault.

Takeaways

• The speaker views TSLA as a victim of irrational market fear, creating a potential buying opportunity for long-term investors.
• The company's competitive advantages are strengthening, particularly its ability to undercut legacy automakers on price in key markets like Europe.
• Future growth drivers like Robotaxi and Optimus are progressing well but are being "entirely discounted" by the current market, suggesting long-term upside that is not reflected in the current stock price.